MedPath

双鹤天安药业(贵州)股份有限公司

Ownership
-
Established
2002-12-13
Employees
-
Market Cap
-
Website
http://www.itianan.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

24

NMPA:24

Drug Approvals

Cefalexin Capsules

Product Name
头孢氨苄胶囊
Approval Number
国药准字H52020261
Approval Date
Aug 1, 2024
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H52020258
Approval Date
Aug 1, 2024
NMPA

Glibenclamide Tablets

Product Name
格列本脲片
Approval Number
国药准字H52020259
Approval Date
Aug 1, 2024
NMPA

Norfloxacin Capsules

Product Name
诺氟沙星胶囊
Approval Number
国药准字H52020260
Approval Date
Aug 1, 2024
NMPA

Metformin Hydrochloride Enteric-coated Tablets

Product Name
盐酸二甲双胍肠溶片
Approval Number
国药准字H52020960
Approval Date
Jun 7, 2024
NMPA

Metformin Hydrochloride Enteric-coated Tablets

Product Name
盐酸二甲双胍肠溶片
Approval Number
国药准字H20073383
Approval Date
Jun 7, 2024
NMPA

Metformin Hydrochloride Enteric-coated Tablets

Product Name
盐酸二甲双胍肠溶片
Approval Number
国药准字H20073382
Approval Date
Jun 7, 2024
NMPA

Metformin Hydrochlorride Tablets

Product Name
盐酸二甲双胍片
Approval Number
国药准字H52020469
Approval Date
Jun 7, 2024
NMPA

Calcium Dobesilate Capsules

Product Name
安多明
Approval Number
国药准字H20010481
Approval Date
Jun 6, 2024
NMPA

Glimepiride Tablets

Product Name
安多美
Approval Number
国药准字H20010561
Approval Date
Jun 6, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath